› ‹
  • 1
  • 2
  • 3
  • 4
  • 5

About us

MBM ScienceBridge GmbH evaluates, protects and commercialises inventions from universities and research institutions. It was founded in 2004 as a wholly-owned subsidiary of the Georg-August-Universität Göttingen Public Law Foundation.

We see it as our task to motivate scientists to consider their own research results from the point of view of a commercially relevant invention and to report these to their employer as a employee invention.

In the case of promising inventions, we coordinate the filing of a patent application with external, specialised patent attorneys.

In the next step, we present the invention to companies worldwide in order to identify interested partners who can further develop the invention into a product and commercialise it.

MBM ScienceBridge GmbH Techno­logy offers MBM ScienceBridge GmbH

MBM ScienceBridge GmbH Techno­logy offers MBM ScienceBridge GmbH

Collaboration Accelerates Innovation in Ultrafast Electron Microscopy, Enabling Cutting-Edge Research and Industrial Applications

Göttingen, 2.12.2024

JEOL-IDES, a leading company in the development of scientific instruments, has licensed an innovative electron beam technology from the Max Planck Institute for Multidisciplinary Sciences (MPI-NAT) and the Georg-August-University Göttingen (Germany). Developed in the research team led by Professor Claus Ropers, the technology drastically enhances ultrafast transmission electron microscopy (UTEM), providing unprecedented precision for advanced imaging applications.

read more

UMG and SubRed Therapeutics aim to jointly develop a therapy for treatment of a rare, devastating childhood disease

Göttingen, 14.6.2023

In the Department of Pediatrics and Adolescent Medicine at UMG, scientists led by Dr. Lars Schlotawa have developed a therapeutic approach that may lead to the first effective treatment of the rare neurometabolic disease MSD (multiple sulfatase deficiency). Through the mediation of MBM ScienceBridge, the Australian pharmaceutical company SubRed Therapeutics, a subsidiary of Tarnagulla Ventures, was chosen as a partner for further development of the therapeutic approach. The common goal of UMG and SubRed is to jointly develop a therapy and achieve its approval as the first drug for the treatment of MSD.

read more

Our Partners

Georg-August-Universität Göttingen Universitätsmedizin Göttingen Universität Hildesheim
Leuphana Stiftung Tierärztliche Hochschule Hannover
IFNANO Hochschule Hannover TransferAllianz
TU Clausthal Ostfalia Measurement Valley
     

 

Looking for innovation

MBM ScienceBridge GmbH supports scientists, evaluates inventions, oversees applications for intellectual property rights and out-licenses patents of universities and research institutions in Göttingen and Lower Saxony.

Our company evaluates, protects and commercializes inventions of higher education institutions and research facilities. It was founded as a private company and wholly owned subsidiary of the University of Göttingen, Public Law Foundation, in 2004.

Office of MBM ScienceBridge GmbH:
You can find the office of the MBM ScienceBridge GmbH at Hans-Adolf-Krebs-Weg 1, 37077 Göttingen on the northern campus of the Georg-August-University Göttingen.

Home I Imprint | Data Privacy | Premium Partner Access | Sitemap

A subsidiary of

Copyright © 2025 MBM ScienceBridge GmbH. All Rights Reserved.
Joomla! is Free Software released under the GNU General Public License.

A subsidiary of

Georg-August-Universität Göttingen